Citius Pharmaceuticals's total assets for Q4 2025 were $130.94M, an increase of 2.55% from the previous quarter. CTXR total liabilities were $53.41M for the fiscal quarter, a -11.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.